Detalles de la búsqueda
1.
Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group.
J Clin Oncol
; 16(3): 914-9, 1998 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-9508173
2.
Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group.
J Clin Oncol
; 16(9): 3037-43, 1998 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9738573
3.
Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
J Clin Oncol
; 18(14): 2665-75, 2000 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-10894865
4.
Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: a report from the Children's Cancer Group.
J Clin Oncol
; 15(8): 2780-5, 1997 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-9256119
5.
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
J Clin Oncol
; 19(11): 2812-20, 2001 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11387352
6.
Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group.
Clin Cancer Res
; 4(1): 45-52, 1998 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-9516951
7.
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.
Clin Cancer Res
; 7(1): 58-67, 2001 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11205919
8.
Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group.
Leuk Lymphoma
; 43(10): 1945-50, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12481889
9.
Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemia and lymphoma.
J Immunother
; 24(6): 511-6, 2001.
Artículo
en Inglés
| MEDLINE | ID: mdl-11759074
10.
A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group.
Cancer
; 80(2): 311-6, 1997 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-9217045
11.
A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors.
Cancer
; 83(4): 813-6, 1998 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-9708950
12.
Phase I study of CI-958 in children and adolescents with recurrent solid tumors.
Cancer
; 91(6): 1166-9, 2001 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11267962
13.
Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia.
Cancer J Sci Am
; 6 Suppl 1: S39-44, 2000 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-10685657
14.
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.
J Pediatr Hematol Oncol
; 23(1): 30-8, 2001 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11196267
15.
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group.
Blood
; 94(5): 1537-44, 1999 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10477677
Resultados
1 -
15
de 15
1
Próxima >
>>